BSX vs CRI · P/E 20, rev $10.65B vs P/E 7.0, rev $1.30B
Boston Scientific Corp (BSX) versus Carter’s Inc (CRI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Carter’s Inc (CRI) is a apparel retail company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CRI revenue for 2026-07-04 was $1.30B. Net income was $119.3M. Revenue was up 90.4% from 2026-04-04 to 2026-07-04. CRI currently screens at market cap $1.15B and trailing P/E 7.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CRI currently screens at market cap $1.15B and trailing P/E 7.0.
Not investment advice. Open the BSX and CRI stock pages for the full models.
Not investment advice.